Form 4: Kamada Ltd. Insider Option Transactions

Nir Livneh, VP, General Counsel of Kamada Ltd., reported transactions involving employee stock options on April 7, 2026.

Summary

• Nir Livneh, VP, General Counsel of Kamada Ltd., reported transactions related to employee stock options on April 7, 2026.
• These transactions involved the acquisition (A) and disposition (D) of various employee stock options with exercise prices ranging from $5.33 to $7.50.
• The options are exercisable on various dates between April 23, 2024, and October 22, 2029, with expiration dates in October 2029 and October 2035.
• All reported securities are beneficially owned indirectly and held by a trustee under the Company's 2011 Share Award Plan.
• The exercise prices were adjusted due to a cash dividend distribution declared by the board of directors on March 11, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider option transactions and adjustments, without indicating significant positive or negative corporate events.

Positives

• The filing indicates continued engagement of key management personnel with company equity through stock options.
• The adjustment of option prices due to a dividend distribution suggests a mechanism to protect the value of employee awards.

Negatives

• The filing details dispositions of options, which could imply some level of selling or reallocation by the reporting person, though the context of trustee holding needs further clarification.
• The specific details of the 'disposition' transactions (Code D) are not fully elaborated beyond the option details themselves.

Risks

• The reliance on a trustee for holding options introduces a layer of complexity and potential governance considerations.
• The adjustment of option prices due to dividends, while protective, can also complicate the valuation and understanding of the original grant terms.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions related to stock options.

Management Comments

• The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026.
• There are no other changes to the terms and conditions of the option award.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in the biopharmaceutical sector, reflecting management's alignment with shareholder interests through equity participation. The adjustments to option prices due to dividends are common practices to maintain the intended value of equity compensation.

Corporate Governance

Stakeholder Impact

• Shareholders: The filing provides transparency into insider equity holdings and transactions, which is a standard aspect of corporate governance.
• Employees: The adjustment of option prices due to dividends ensures that the value of their equity compensation is not diminished by such distributions.
• Management: Confirms continued equity interest and participation in the company's performance through stock options.

Next Steps

• Monitoring future option exercises and potential sales by Nir Livneh.
• Observing any further adjustments or grants related to Kamada Ltd.'s equity incentive plans.

Key Dates

Keywords

Kamada Ltd., KMDA, Form 4, Insider Trading, Stock Options, Beneficial Ownership, Nir Livneh, SEC Filing, Employee Stock Options, Vesting, Trustee